Prevalence of Helicobacter Pylori Isolated from Patients with Irritable Bowel Syndrome

Authors

  • Daniah M. Hamid AL-Nahrain University, DNA Forensic Center for Research and Training, Baghdad, Iraq Author
  • Rawaa AlChalabi Al-Nahrain University, College of Biotechnology Author
  • Fatimah A. Abdul Jabbar Al-Nahrain University, College of Biotechnology Author
  • Ahmed N. Aljanabi Baghdad Health Directorate, Rusafa Author

DOI:

https://doi.org/10.61841/7kvzzq76

Keywords:

Helicobacter Pylori, H. Pylori Ag, Irritable Bowel Syndrome

Abstract

One hundred seventy-two stool samples of suspected patients with irritable bowel syndrome were examined by H. pylori Ag Strip to detect the positive cases by using the bioNexia Ag kit (USA). Sixty-one patients were infected with H. pylori, while one hundred and eleven of them were negative patients for H. pylori and had irritable bowel syndrome and were taken as a control group. This study lasted from the period of 1st January 2017 to 1st May 2017 at Thatching Hospital/Medicine City. The result showed that there was no significant difference between the positive age cases (35.68 ±37.04) and the negative control (P>0.05). While the results showed that there was a highly significant difference among the age groups < 10 years, 4 (5.7%), and the negative control group, 13 (11.7%); 10-30 years, 24 (38.5) % compared with the control group, 23 (20.7%); 31-50 years, 21 (36.1%) compared with the control group, 52 (46.8%); and 51-70 years, 12 (19.7%) in comparison with the control group, 23 (20.7%), respectively (P < 0.01). The results also showed that there was no significant difference between the male gender 30 (48.4%) compared to the control group 45 (40.1%) and between the female gender 31 (51.6%) in comparison with the control group 57 (59.9%) (P > 0.05). In regard to the clinical symptoms of the situated groups, 61 (100%) compared to the control group 46 (42.4%). The current study indicated a highly significant difference between the patients with abdominal pain, 36 (59.0%), and the control group, 42 (38.3%), and between irritable bowel syndrome, 61 (100%), and the control group, 46 (42.4%) (P < 0.01). While there was a nonsignificant difference between patients with diarrhea, 17 (30.3%), compared to the control group, 28 (25.7%), and between patients with vomiting, 36 (59.0%), in comparison with the control group, 42 (38.3%), and between patients with weight loss, 11 (18.0%), compared with the control, 16 (14.0%), (P > 0.05). 

Downloads

Download data is not yet available.

References

[1] MA Hassan, MA Ahad, MH Rahman et al., Association between cytotoxin-producing H. pylori and gastric carcinoma, Bang Med J Khulna 2016; 49 : 13-17.2.

[2] Sara A. Mohamad, A. P., Mahsa, M., et al., The prevalence of H. pylori is decreasing in Iranian patients, J. of List, 2015 Spring; 8(Suppl1): S23–S29.

[3] Hoang, T. T. H., Bengtsson, C., Phung, D. C., et al., Seroprevalence of Helicobacter pylori Infection in Urban and Rural Vietnam, J. of Clin Diagn Lab Immunol. 2005 Jan; 12(1): 81–85.

[4] Herszényi L and Tulassay Z. Epidemiology of gastrointestinal and liver tumors. J. of Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):249-58.

[5] Nadine R., Dieter Schmalzing, D., and Russell, R. Bridging Analytical Methods for Release and Stability Testing: Technical, Quality, and Regulatory Considerations, J. of Bioprocess 4, 2016, 4:44.

[6] Hoang, T.H.H. and Wheeldon, T.U. Enzyme-Linked Immunosorbent Assay for Helicobacter pylori Needs Adjustment for the Population Investigated, J. of Clin. Micro. 2017, Volume 55, Issue 7.

[7] Kao CY, Sheu BS, and Wu JJ. Helicobacter pylori infection: An overview of bacterial virulence factors

and pathogenesis, Biomed J. 2016 Feb;39(1):14-23.

[8] Technical problems, contact, URL: http://www.its.msstate.edu/software/ University, All right reserved.

2017.

[9] Traci, L.T. and Morris, J. Beyond the stomach: An updated view of Helicobacter pylori pathogenesis.

diagnosis, and treatment, World J Gastroenterol. 2014 Sep 28; 20(36): 12781–12808.

[10] Khedmat, H., MD, Karbasi-Afshar, R., Agah, Sh., et al; Helicobacter pylori Infection in the general

population: A Middle Eastern perspective, Caspian J Intern Med. 2013 Autumn; 4(4): 745–753.

[11] Khedmat, H., MD, Afshar, R., Agah, Sh., et al., Helicobacter pylori Infection in the General Population:

A Middle Eastern perspective, Caspian J Intern Med. 2013 Autumn; 4(4): 745–753.

[12] Xiong, F., Xiong, M., Ma, Z., et al., Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study, Gastroenterol ResPract. 2016: 3059201.

[13] James, A. Cotton, Christina B. C. Amat, and Buret, G. Disruptions of Host Immunity and Inflammation by Giardia Duodenalis: Potential Consequences for Co-Infections in the Gastrointestinal Tract, J. of Pathogens. 2015 Dec; 4(4): 764–792.

[14] Chi, E. H. Pylori: Know the Facts, Med. News Today. 11.12.2016.

Downloads

Published

31.07.2020

How to Cite

M. Hamid, D., AlChalabi, R., A. Abdul Jabbar, F., & N. Aljanabi, A. (2020). Prevalence of Helicobacter Pylori Isolated from Patients with Irritable Bowel Syndrome. International Journal of Psychosocial Rehabilitation, 24(5), 4382-4385. https://doi.org/10.61841/7kvzzq76